Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 123

1.

Proposal of criteria for dyserythropoiesis in the diagnosis of myelodysplastic syndromes.

Kawai N, Matsuda A, Jinnai I, Ichimura T, Kayano H, Okamura D, Ishikawa M, Maeda T, Hata T, Miyazaki Y, Asou N, Bessho M, Tomonaga M.

Int J Hematol. 2016 Feb;103(2):227-33. doi: 10.1007/s12185-015-1916-8. Epub 2015 Nov 25.

PMID:
26608365
2.

Correlation between dysplastic lineage and type of cytopenia in myelodysplastic syndromes patients with refractory anemia according to the FAB classification.

Matsuda A, Jinnai I, Iwanaga M, Okamura D, Ishikawa M, Maeda T, Hata T, Kawai N, Miyazaki Y, Bessho M, Tomonaga M.

Am J Clin Pathol. 2013 Aug;140(2):253-7. doi: 10.1309/AJCPJEFPNTMM3KSH.

PMID:
23897263
3.

The role of HLA-matched unrelated transplantation in adult patients with Ph chromosome-negative ALL in first remission. A decision analysis.

Kako S, Morita S, Sakamaki H, Iida H, Kurokawa M, Miyamura K, Kanamori H, Hara M, Kobayashi N, Morishima Y, Kawa K, Kyo T, Sakura T, Jinnai I, Takeuchi J, Miyazaki Y, Miyawaki S, Ohnishi K, Naoe T, Kanda Y.

Bone Marrow Transplant. 2013 Aug;48(8):1077-83. doi: 10.1038/bmt.2013.4. Epub 2013 Feb 4.

PMID:
23376818
4.

[Aplastic anemia complicated with ulcerative colitis].

Shimada T, Maeda T, Ishikawa M, Okamura D, Ito Y, Wakimoto N, Nakamura Y, Kawai N, Ino H, Jinnai I, Mori S, Matsuda A, Bessho M.

Rinsho Ketsueki. 2012 Feb;53(2):224-8. Japanese.

PMID:
22450583
5.

Morphologic analysis in myelodysplastic syndromes with del(5q) treated with lenalidomide. A Japanese multiinstitutional study.

Matsuda A, Taniwaki M, Jinnai I, Harada H, Watanabe M, Suzuki K, Yanagita S, Suzuki T, Yoshida Y, Kimura A, Tsudo M, Tohyama K, Takatoku M, Ozawa K.

Leuk Res. 2012 May;36(5):575-80. doi: 10.1016/j.leukres.2011.11.011. Epub 2011 Dec 15.

PMID:
22172461
6.

Social meaning of alcohol-related flushing among university students in China.

Newman IM, Jinnai I, Zhao J, Huang Z, Pu J, Qian L.

Asia Pac J Public Health. 2013 Sep;25(5):409-19. doi: 10.1177/1010539511420702. Epub 2011 Sep 13.

PMID:
21914706
7.

A decision analysis of allogeneic hematopoietic stem cell transplantation in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission who have an HLA-matched sibling donor.

Kako S, Morita S, Sakamaki H, Ogawa H, Fukuda T, Takahashi S, Kanamori H, Onizuka M, Iwato K, Suzuki R, Atsuta Y, Kyo T, Sakura T, Jinnai I, Takeuchi J, Miyazaki Y, Miyawaki S, Ohnishi K, Naoe T, Kanda Y.

Leukemia. 2011 Feb;25(2):259-65. doi: 10.1038/leu.2010.260. Epub 2010 Nov 12.

PMID:
21072046
8.

Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia: the JALSG-ALL97 study.

Jinnai I, Sakura T, Tsuzuki M, Maeda Y, Usui N, Kato M, Okumura H, Kyo T, Ueda Y, Kishimoto Y, Yagasaki F, Tsuboi K, Horiike S, Takeuchi J, Iwanaga M, Miyazaki Y, Miyawaki S, Ohnishi K, Naoe T, Ohno R.

Int J Hematol. 2010 Oct;92(3):490-502. doi: 10.1007/s12185-010-0672-z. Epub 2010 Sep 10.

PMID:
20830614
9.

Differences in the distribution of subtypes according to the WHO classification 2008 between Japanese and German patients with refractory anemia according to the FAB classification in myelodysplastic syndromes.

Matsuda A, Germing U, Jinnai I, Araseki K, Kuendgen A, Strupp C, Iwanaga M, Miyazaki Y, Hata T, Bessho M, Gattermann N, Tomonaga M.

Leuk Res. 2010 Aug;34(8):974-80. doi: 10.1016/j.leukres.2009.11.015.

PMID:
20022110
10.

[Correlation of quantification of major bcr-abl mRNA between TMA (transcription mediated amplification) method and real-time quantitative PCR].

Yagasaki F, Niwa T, Abe A, Ishikawa M, Kato C, Ogura K, Sasaki H, Kyo T, Jinnai I, Bessyo M, Miyamura K.

Rinsho Ketsueki. 2009 Jun;50(6):481-7. Japanese.

PMID:
19571508
11.

A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL.

Tojo A, Usuki K, Urabe A, Maeda Y, Kobayashi Y, Jinnai I, Ohyashiki K, Nishimura M, Kawaguchi T, Tanaka H, Miyamura K, Miyazaki Y, Hughes T, Branford S, Okamoto S, Ishikawa J, Okada M, Usui N, Tanii H, Amagasaki T, Natori H, Naoe T.

Int J Hematol. 2009 Jun;89(5):679-88. doi: 10.1007/s12185-009-0327-0. Epub 2009 May 19.

PMID:
19449194
12.

Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size: a report by the Nagasaki CML Study Group.

Sakai M, Miyazaki Y, Matsuo E, Moriuchi Y, Hata T, Fukushima T, Imaizumi Y, Imanishi D, Taguchi J, Iwanaga M, Tsushima H, Inoue Y, Takasaki Y, Tsuchiya T, Komoda M, Ando K, Horio K, Moriwaki Y, Tominaga S, Itonaga H, Nagai K, Tsukasaki K, Tsutsumi C, Sawayama Y, Yamasaki R, Ogawa D, Kawaguchi Y, Ikeda S, Yoshida S, Onimaru Y, Tawara M, Atogami S, Koida S, Joh T, Yamamura M, Matsuo Y, Soda H, Nonaka H, Jinnai I, Kuriyama K, Tomonaga M.

Int J Hematol. 2009 Apr;89(3):319-325. doi: 10.1007/s12185-009-0263-z. Epub 2009 Mar 6.

PMID:
19266256
13.

Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia.

Sakamaki H, Ishizawa KI, Taniwaki M, Fujisawa S, Morishima Y, Tobinai K, Okada M, Ando K, Usui N, Miyawaki S, Utsunomiya A, Uoshima N, Nagai T, Naoe T, Motoji T, Jinnai I, Tanimoto M, Miyazaki Y, Ohnishi K, Iida S, Okamoto S, Seriu T, Ohno R.

Int J Hematol. 2009 Apr;89(3):332-341. doi: 10.1007/s12185-009-0260-2. Epub 2009 Mar 5.

PMID:
19263190
14.

Adhesion-dependent growth of primary adult T cell leukemia cells with down-regulation of HTLV-I p40Tax protein: a novel in vitro model of the growth of acute ATL cells.

Nagai K, Jinnai I, Hata T, Usui T, Sasaki D, Tsukasaki K, Sugahara K, Hishikawa Y, Yamada Y, Tanaka Y, Koji T, Mano H, Kamihira S, Tomonaga M.

Int J Hematol. 2008 Dec;88(5):551-564. doi: 10.1007/s12185-008-0207-z. Epub 2008 Dec 2.

PMID:
19043810
15.

Prospective monitoring of BCR-ABL1 transcript levels in patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia undergoing imatinib-combined chemotherapy.

Yanada M, Sugiura I, Takeuchi J, Akiyama H, Maruta A, Ueda Y, Usui N, Yagasaki F, Yujiri T, Takeuchi M, Nishii K, Kimura Y, Miyawaki S, Narimatsu H, Miyazaki Y, Ohtake S, Jinnai I, Matsuo K, Naoe T, Ohno R; Japan Adult Leukemia Study Group.

Br J Haematol. 2008 Nov;143(4):503-10. doi: 10.1111/j.1365-2141.2008.07377.x.

PMID:
18986386
16.

Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts.

Mufti GJ, Bennett JM, Goasguen J, Bain BJ, Baumann I, Brunning R, Cazzola M, Fenaux P, Germing U, Hellström-Lindberg E, Jinnai I, Manabe A, Matsuda A, Niemeyer CM, Sanz G, Tomonaga M, Vallespi T, Yoshimi A; International Working Group on Morphology of Myelodysplastic Syndrome.

Haematologica. 2008 Nov;93(11):1712-7. doi: 10.3324/haematol.13405. Epub 2008 Oct 6.

17.

The GAS5 (growth arrest-specific transcript 5) gene fuses to BCL6 as a result of t(1;3)(q25;q27) in a patient with B-cell lymphoma.

Nakamura Y, Takahashi N, Kakegawa E, Yoshida K, Ito Y, Kayano H, Niitsu N, Jinnai I, Bessho M.

Cancer Genet Cytogenet. 2008 Apr 15;182(2):144-9. doi: 10.1016/j.cancergencyto.2008.01.013.

PMID:
18406879
18.

Karyotype at diagnosis is the major prognostic factor predicting relapse-free survival for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapy.

Yanada M, Takeuchi J, Sugiura I, Akiyama H, Usui N, Yagasaki F, Nishii K, Ueda Y, Takeuchi M, Miyawaki S, Maruta A, Narimatsu H, Miyazaki Y, Ohtake S, Jinnai I, Matsuo K, Naoe T, Ohno R; Japan Adult Leukemia Study Group.

Haematologica. 2008 Feb;93(2):287-90. doi: 10.3324/haematol.11891. Epub 2008 Jan 26.

19.
20.

[POEMS syndrome presenting with transient immunoglobulin isotype switching after successful treatment with autologous peripheral blood stem cell transplantation].

Nakamura Y, Sato Y, Ito Y, Maeda T, Takahashi N, Kawai N, Jinnai I, Bessho M, Kinoshita S, Yamamoto T.

Rinsho Ketsueki. 2007 Aug;48(8):642-6. Japanese.

PMID:
17867301
21.

[Concept and classification of chronic myeloproliferative disorders].

Jinnai I.

Nihon Naika Gakkai Zasshi. 2007 Jul 10;96(7):1331-7. Review. Japanese. No abstract available.

PMID:
17682417
22.

[Acute lymphoblastic leukemia].

Jinnai I.

Nihon Rinsho. 2007 Jan 28;65 Suppl 1:245-9. Review. Japanese. No abstract available.

PMID:
17474418
23.

Imatinib provides durable molecular and cytogenetic responses in a practical setting for both newly diagnosed and previously treated chronic myelogenous leukemia: a study in nagasaki prefecture, Japan.

Matsuo E, Miyazaki Y, Tsutsumi C, Inoue Y, Yamasaki R, Hata T, Fukushima T, Tsushima H, Imanishi D, Imaizumi Y, Iwanaga M, Sakai M, Ando K, Sawayama Y, Ogawa D, Kawaguchi Y, Nagai K, Tsukasaki K, Ikeda S, Moriuchi Y, Yoshida S, Honda M, Taguchi J, Onimaru Y, Tsuchiya T, Tawara M, Atogami S, Yamamura M, Soda H, Yoshida Y, Matsuo Y, Nonaka H, Joh T, Takasaki Y, Kawasaki C, Momita S, Jinnai I, Kuriyama K, Tomonaga M.

Int J Hematol. 2007 Feb;85(2):132-9.

PMID:
17321991
24.

Improvement of criteria for refractory cytopenia with multilineage dysplasia according to the WHO classification based on prognostic significance of morphological features in patients with refractory anemia according to the FAB classification.

Matsuda A, Germing U, Jinnai I, Iwanaga M, Misumi M, Kuendgen A, Strupp C, Miyazaki Y, Tsushima H, Sakai M, Bessho M, Gattermann N, Aul C, Tomonaga M.

Leukemia. 2007 Apr;21(4):678-86. Epub 2007 Feb 1.

PMID:
17268513
25.

3. Imatinib therapy in chronic myelogenous leukemia.

Jinnai I.

Intern Med. 2007;46(2):95-7. Epub 2007 Jan 15. Review. No abstract available.

26.

Clinical features and outcome of T-lineage acute lymphoblastic leukemia in adults: a low initial white blood cell count, as well as a high count predict decreased survival rates.

Yanada M, Jinnai I, Takeuchi J, Ueda T, Miyawaki S, Tsuzuki M, Hatta Y, Usui N, Wada H, Morii T, Matsuda M, Kiyoi H, Okada M, Honda S, Miyazaki Y, Ohno R, Naoe T.

Leuk Res. 2007 Jul;31(7):907-14. Epub 2006 Sep 26.

PMID:
17005250
27.

Serum levels of Thl/Th2 cytokines, angiogenic growth factors, and other prognostic factors in young adult patients with hemophagocytic syndrome.

Murohashi I, Yoshida K, Ihara N, Wakao D, Yagasaki F, Nakamura Y, Kawai N, Matsuda A, Jinnai I, Bessho M.

Lab Hematol. 2006;12(2):71-4.

PMID:
16751133
28.

[Treatment strategies for chronic myeloid leukemia].

Jinnai I.

Rinsho Ketsueki. 2005 Jan;46(1):1-6. Japanese. No abstract available.

PMID:
16708910
29.

Cognitive impairment in people diagnosed with end-stage liver disease evaluated for liver transplantation.

Sorrell JH, Zolnikov BJ, Sharma A, Jinnai I.

Psychiatry Clin Neurosci. 2006 Apr;60(2):174-81.

30.

Expression of the myeloperoxidase gene in AC133 positive leukemia cells relates to the prognosis of acute myeloid leukemia.

Taguchi J, Miyazaki Y, Tsutsumi C, Sawayama Y, Ando K, Tsushima H, Fukushima T, Hata T, Yoshida S, Kuriyama K, Honda S, Jinnai I, Mano H, Tomonaga M.

Leuk Res. 2006 Sep;30(9):1105-12. Epub 2006 Feb 2.

PMID:
16457884
31.

[Diffuse large B-cell lymphoma with strongly positive MIB-1 stain and clinical features resembling Burkitt lymphoma].

Wakimoto N, Misumi M, Maeda T, Shimada T, Wakao D, Sato Y, Takahashi N, Sugahara Y, Yoshida K, Yagasaki F, Nakamura Y, Kawai N, Matsuda A, Kayano H, Jinnai I, Bessho M.

Rinsho Ketsueki. 2005 Jun;46(6):458-62. Japanese.

PMID:
16447728
32.

[Successful treatment with CHOP therapy for progressive of primary macroglobulinemia without further increase of serum IgM].

Wakimoto N, Misumi M, Maeda T, Shimada T, Wakao D, Sato Y, Takahashi N, Sugahara Y, Yoshida K, Yagasaki F, Ito Y, Nakamura Y, Kawai N, Matsuda A, Jinnai I, Bessho M.

Rinsho Ketsueki. 2005 Jul;46(7):536-8. Japanese.

PMID:
16440749
33.

High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group.

Yanada M, Takeuchi J, Sugiura I, Akiyama H, Usui N, Yagasaki F, Kobayashi T, Ueda Y, Takeuchi M, Miyawaki S, Maruta A, Emi N, Miyazaki Y, Ohtake S, Jinnai I, Matsuo K, Naoe T, Ohno R; Japan Adult Leukemia Study Group.

J Clin Oncol. 2006 Jan 20;24(3):460-6. Epub 2005 Dec 12.

PMID:
16344315
34.

[Treatment of chronic myelogenous leukemia by using imatinib].

Jinnai I.

Nihon Naika Gakkai Zasshi. 2005 Sep 10;94(9):1819-24. Review. Japanese. No abstract available.

PMID:
16223141
35.

Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes.

Matsuda A, Germing U, Jinnai I, Misumi M, Kuendgen A, Knipp S, Aivado M, Iwanaga M, Miyazaki Y, Tsushima H, Sakai M, Bessho M, Tomonaga M.

Blood. 2005 Oct 15;106(8):2633-40. Epub 2005 Jun 21.

36.

Successful treatment with imatinib mesylate in a case of minor BCR-ABL-positive acute myelogenous leukemia.

Ito K, Tominaga K, Suzuki T, Jinnai I, Bessho M.

Int J Hematol. 2005 Apr;81(3):242-5.

PMID:
15814335
37.

Efficacy and safety of imatinib mesylate for patients in the first chronic phase of chronic myeloid leukemia: results of a Japanese phase II clinical study.

Morishima Y, Ogura M, Nishimura M, Yazaki F, Bessho M, Mizoguchi H, Chiba S, Hirai H, Tauchi T, Urabe A, Takahashi M, Ohnishi K, Yokozawa T, Emi N, Hirano M, Shimazaki C, Nakao S, Kawai Y, Fujimoto M, Taguchi H, Jinnai I, Ohno R.

Int J Hematol. 2004 Oct;80(3):261-6.

PMID:
15540902
38.

Combination of intensive chemotherapy and imatinib can rapidly induce high-quality complete remission for a majority of patients with newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia.

Towatari M, Yanada M, Usui N, Takeuchi J, Sugiura I, Takeuchi M, Yagasaki F, Kawai Y, Miyawaki S, Ohtake S, Jinnai I, Matsuo K, Naoe T, Ohno R; Japan Adult Leukemia Study Group.

Blood. 2004 Dec 1;104(12):3507-12. Epub 2004 Aug 17.

39.

Long-term improvement of anaemia in a patient with aplastic anaemia by short-term administration of pegylated recombinant human megakaryocyte growth and development factor.

Matsuda A, Misumi M, Ishikawa M, Yagasaki F, Jinnai I, Bessho M, Mizoguchi H.

Br J Haematol. 2004 Jun;125(6):818-9. No abstract available. Erratum in: Br J Haematol. 2004 Jul;126(2):284-5.

PMID:
15180875
40.

Membranous nephropathy after allogeneic stem cell transplantation: report of 2 cases.

Tsutsumi C, Miyazaki Y, Fukushima T, Yoshida S, Taguchi J, Miyake C, Miyazaki M, Kohno S, Jinnai I, Tomonaga M.

Int J Hematol. 2004 Feb;79(2):193-7.

PMID:
15005351
41.

[Intensive multi-drug chemotherapy for acute myeloid leukemia in a renal allograft recipient].

Yamasaki J, Hata T, Fuchigami K, Togami K, Honda M, Fukushima T, Miyazaki Y, Jinnai I, Kuriyama K, Tomonaga M.

Rinsho Ketsueki. 2003 Oct;44(10):1015-9. Japanese.

PMID:
14639948
42.

Differential response to stem cell factor and Flt3 ligand by the FAB subtype in acute myeloid leukemia clonogenic cells.

Murohashi I, Yoshida K, Kishimoto K, Takahashi T, Wakao D, Jinnai I, Yagasaki F, Kawai N, Suzuki T, Matsuda A, Hirashima K, Bessho M.

J Interferon Cytokine Res. 2002 Mar;22(3):335-41.

PMID:
12034041
43.

[Antileukemic drug--a selective inhibitor of BCR-ABL tyrosine kynase, imatinib(STI571)].

Jinnai I.

Nihon Rinsho. 2002 Jan;60(1):88-94. Review. Japanese.

PMID:
11808344
44.

[Clinical manifestations and staging system].

Jinnai I.

Nihon Rinsho. 2001 Dec;59(12):2311-5. Review. Japanese.

PMID:
11766331
45.

HTLV-1 proviruses encoding non-functional TAX in adult T-cell leukemia.

Okazaki S, Moriuchi R, Yosizuka N, Sugahara K, Maeda T, Jinnai I, Tomonaga M, Kamihira S, Katamine S.

Virus Genes. 2001;23(2):123-35.

PMID:
11724264
46.

Effect of a selective Abl tyrosine kinase inhibitor, STI571, on in vitro growth of BCR-ABL-positive acute lymphoblastic leukemia cells.

Kawaguchi Y, Jinnai I, Nagai K, Yagasaki F, Yakata Y, Matsuo T, Kuriyama K, Tomonaga M.

Leukemia. 2001 Apr;15(4):590-4.

PMID:
11368361
47.

De novo acute myeloid leukemia in the elderly; a consistent fraction of long-term survivors by standard-dose chemotherapy.

Yoshida S, Kuriyama K, Miyazaki Y, Taguchi J, Fukushima T, Honda M, Hayashibara T, Nagai K, Atogami S, Toriya K, Soda H, Nonaka H, Momita S, Jinnai I, Amenomori T, Kusano M, Yoshida Y, Ikeda S, Matsuo T, Tomonaga M.

Leuk Res. 2001 Jan;25(1):33-38.

PMID:
11137558
48.

Allogeneic bone marrow transplantation improves the outcome of de novo AML with trilineage dysplasia (AML-TLD).

Taguchi J, Miyazaki Y, Yoshida S, Fukushima T, Moriuchi Y, Jinnai I, Matsuo T, Kuriyama K, Tomonaga M.

Leukemia. 2000 Nov;14(11):1861-6.

PMID:
11069020
49.
50.

Recovery of hematopoietic progenitor cells in patients with severe aplastic anemia who obtained good clinical response with a combination therapy of immunosuppressive agents and recombinant human granulocyte colony-stimulating factor.

Matsuo Y, Iwanaga M, Mori H, Yoshida S, Kawaguchi Y, Yakata Y, Murata K, Nagai K, Jinnai I, Matsuo T, Kuriyama K, Tomonaga M.

Int J Hematol. 2000 Jul;72(1):37-43.

PMID:
10979207

Supplemental Content

Loading ...
Support Center